{Reference Type}: Journal Article
{Title}: New Insights in ATP Synthesis as Therapeutic Target in Cancer and Angiogenic Ocular Diseases.
{Author}: van Noorden CJF;Yetkin-Arik B;Serrano Martinez P;Bakker N;van Breest Smallenburg ME;Schlingemann RO;Klaassen I;Majc B;Habic A;Bogataj U;Galun SK;Vittori M;Erdani Kreft M;Novak M;Breznik B;Hira VVV;
{Journal}: J Histochem Cytochem
{Volume}: 72
{Issue}: 5
{Year}: 2024 05 11
{Factor}: 4.137
{DOI}: 10.1369/00221554241249515
{Abstract}: Lactate and ATP formation by aerobic glycolysis, the Warburg effect, is considered a hallmark of cancer. During angiogenesis in non-cancerous tissue, proliferating stalk endothelial cells (ECs) also produce lactate and ATP by aerobic glycolysis. In fact, all proliferating cells, both non-cancer and cancer cells, need lactate for the biosynthesis of building blocks for cell growth and tissue expansion. Moreover, both non-proliferating cancer stem cells in tumors and leader tip ECs during angiogenesis rely on glycolysis for pyruvate production, which is used for ATP synthesis in mitochondria through oxidative phosphorylation (OXPHOS). Therefore, aerobic glycolysis is not a specific hallmark of cancer but rather a hallmark of proliferating cells and limits its utility in cancer therapy. However, local treatment of angiogenic eye conditions with inhibitors of glycolysis may be a safe therapeutic option that warrants experimental investigation. Most types of cells in the eye such as photoreceptors and pericytes use OXPHOS for ATP production, whereas proliferating angiogenic stalk ECs rely on glycolysis for lactate and ATP production. (J Histochem Cytochem XX.XXX-XXX, XXXX).